KCNA3 and prostate cancer: Besides of Jurkat T cells, lovastatin inhibits proliferation and induces apoptosis of many other Kv1.3-expressing cancer cells, such as myeloid leukemia (OCIAML-3), breast adenocarcinoma (MCF-7 and MDA-MB-231), colon carcinoma (LoVo and SW-480), glioblastoma (U87), and prostate cancer (LNCaP) (52).